References
- Attman P-O., Aurell M, Johansson G. Effects of metoprolol and propranolol on furosemidestimulated renin release in healthy subjects. Eur. J. clin. Pharmacol. 1977; 8: 20
- Aurell M., Delin K, Granerus G. Observations on the use and limitations of renal vein renins in hypertensive patients. Contr. Nephrol. 1978; 1: 146
- Aurell M., Fritjofsson A R, Granerus G, Grimby G. Renal extraction of p-Aminohippurate: physiological and clinical observations. Contr. Nephrol. 1978; 1: 14
- Aurell M., Pettersson U, Berglund G. The renin angiotensin system in essential hypertension. Lancet 1975; ii: 342
- Bozoviec L, Castenfors J. Effect of hydralazine and pentolinum on renin release caused by bleeding in rats. Acta med. scand. Suppl. 1967; 472: 224
- Bröchner-Mortensen J. A simple method for the determination of glomerular filtration rate. Scand. J. clin. Lab. Invest. 1972; 30: 271
- Coulson R, Bowman H. Excretion and degradation of exogenous adenosine 3, 5-monophosphate by isolated perfused rat kidney. Life Sci 1974; 14: 545
- Davis J. O., Freeman R. H. Mechanisms regulating renin release. Physiol. Rev. 1976; 56: 1
- Giese J., Aurell M, Munck O. Peripheral and renal venous plasma renin concentration in hypertensive patients with unilateral renal or renovascular disease. Scand. J. Urol. Nephrol. 1972; 6(Suppl. 15)39
- Giese J., Jörgensen M., Nielsen M. D., Lund J. O., Munck O. Plasma renin concentration measured by use of radioimmunoassay for angiotensin I. Scand. J. clin. Lab. Invest. 1970; 26: 355
- Hamet P., Kuchel O., Fraysse J, Genest J. Plasma adenosine 3, 5-cyclic monophosphate in human hypertension. Can. med. Assoc. J. 1974; 111: 323
- Hamet P., Stouder D. A., Ginn H. E., Hardman J.G., Liddle G. W. Studies of the elevated extracellular concentration of cyclic AMP in uremic man. J. clin. Invest. 1975; 56: 339
- Kopp U., Aurell M., Fellenius E., Nilsson I M, Åblad B. To what degree do beta-adreno-receptors involved in the renin release respond to renal sympathetic nerve stimulation?. Abstract XXVII:th Int. Congr. Physiol. Sci. Paris 1977
- Kuchel O., Messerli F. H., Tolis G., Hamet P., Fraysse J., Cartier P., Roy P., Boucher R, Genest J. Renal vein plasma adenosine 3,5-cyclic monophosphate in renovascular hypertension. Can. med. Assoc. J. 1977; 116: 992
- Laragh J. H., Sealey J. E., Buhler F. R., Waughan E. D., Bumer H. R., Garsas H, Baef L. The renin axis and vasoconstriction volume analysis for understanding and treating renovascular and renal hypertension. Am. J. Med. 1975; 58
- Selstam G., Jansson P. O., Eden S. Effect of LH on the release of cyclic AMP by the rabbit ovary perfused in vivo and in vitro. J. Reprod. Fact., 46: 355–1976
- Åblad B. A study of the mechanism of the hemodynamic effects of hydralazine in man. Acta Pharmacol. et Toxicol. 1963; 20: suppl.